Clinical Trial Update: Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of Cesamet for pain in chemotherapy-induced peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• CESAMET (nabilone)

Snippet

Sponsor: NEMA Research, Inc. | Conditions: Peripheral Neuropathy, Antineoplastic Combined Chemotherapy Protocols | Phase 4 | Status: COMPLETED